Drug Approval | May 19, 2026
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Baxfendy works in a fundamentally different way from current therapies
Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management
Access to genomic testing, not therapy cost, is the biggest challenge
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Subscribe To Our Newsletter & Stay Updated
